Boston Partners’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$31.8M Sell
340,275
-82,160
-19% -$7.28M 0.03% 316
2025
Q4
$35.1M Sell
422,435
-46,306
-10% -$3.88M 0.04% 305
2025
Q3
$44.9M Sell
468,741
-5,302
-1% -$427K 0.05% 272
2025
Q2
$33.6M Buy
474,043
+141,004
+42% +$8.04M 0.04% 291
2025
Q1
$16.3M Buy
333,039
+2,966
+0.9% +$188K 0.02% 340
2024
Q4
$23.1M Buy
330,073
+84,481
+34% +$7.02M 0.03% 320
2024
Q3
$25.2M Buy
245,592
+81
+0% +$9.47K 0.03% 305
2024
Q2
$33.7M Buy
245,511
+53,251
+28% +$6.14M 0.04% 267
2024
Q1
$20.8M Buy
+192,260
New +$22.9M 0.02% 320
2023
Q1
Sell
-16,045
Closed -$1.27M 693
2022
Q4
$1.27M Buy
16,045
+4,569
+40% +$322K ﹤0.01% 489
2022
Q3
$695K Buy
11,476
+2,061
+22% +$133K ﹤0.01% 555
2022
Q2
$516K Buy
9,415
+2,428
+35% +$141K ﹤0.01% 602
2022
Q1
$528K Sell
6,987
-7,852
-53% -$536K ﹤0.01% 615
2021
Q4
$1.11M Sell
14,839
-47,450
-76% -$2.81M ﹤0.01% 518
2021
Q3
$2.93M Sell
62,289
-18,451
-23% -$803K ﹤0.01% 417
2021
Q2
$3.26M Sell
80,740
-48,127
-37% -$1.99M ﹤0.01% 407
2021
Q1
$5.29M Buy
128,867
+33,716
+35% +$1.26M 0.01% 383
2020
Q4
$2.77M Buy
95,151
+7,090
+8% +$183K ﹤0.01% 399
2020
Q3
$1.94M Sell
88,061
-22,852
-21% -$583K ﹤0.01% 428
2020
Q2
$3.09M Buy
110,913
+1,591
+1% +$38.8K 0.01% 384
2020
Q1
$2M Buy
+109,322
New +$2.54M ﹤0.01% 421

Other funds holding ACLS

Boston Partners's ACLS Position: Q1 2026 in Review

Boston Partners reduced its Axcelis (ACLS) stake by 19% in Q1 2026, selling an estimated $7.28M and leaving 340,275 shares worth $31.8M. The position accounts for 0.03% of the portfolio, ranked #316.

Boston Partners first reported a position in ACLS in Q1 2020 and has held it in 21 quarters since. The position peaked at $44.9M in Q3 2025. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

  • Boston Partners held 340,275 shares of Axcelis worth $31.8M as of Q1 2026.
  • Boston Partners sold 82,160 Axcelis shares in Q1 2026, an estimated $7.28M.
  • Axcelis made up 0.03% of Boston Partners's portfolio in Q1 2026, its #316 holding.
  • Boston Partners first reported a position in Axcelis in Q1 2020 and has held it in 21 quarters since.
  • Boston Partners's Axcelis position peaked at $44.9M in Q3 2025.
  • 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on Boston Partners's 13F filing for Q1 2026, filed 11 May 2026.